Clorazepate Dipotassium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

11 API Suppliers, 7 USDMF, 2 CEP/COS, 1 JDMF, 3 NDC API, 5 Listed Suppliers, $ API Reference Price

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

114 FDF Dossiers, 85 FDA Orange Book, 25 Europe, 3 Canada, 1 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 11.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 22.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 DKSH, 1 Jai Radhe Sales, 5 Faran Shimi Pharmaceutical, 7 Gangwal Healthcare, 2 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 3 DFE Pharma, 1 Finar, 5 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 3 Kerry, 8 Microlex e.U, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 8 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

22 Fillers, Diluents & Binders, 15 Direct Compression, 15 Lubricants & Glidants, 14 Disintegrants & Superdisintegrants, 11 Thickeners and Stabilizers, 10 Granulation, 8 Co-Processed Excipients, 7 Controlled & Modified Release, 5 Coating Systems & Additives, 4 Parenteral, 4 Taste Masking, 3 Emulsifying Agents, 2 Chewable & Orodispersible Aids, 2 Film Formers & Plasticizers, 2 API Stability Enhancers, 2 Rheology Modifiers, 1 Topical, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 NEWS #PharmaBuzz

3 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 28 Finished Drug Prices

MARKET PLACE

2 APIs

2 APIs

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 1 Others

$ Xls

Filters

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Neuraxpharm to increase branded business through upcoming acquisition from Sanofi

12 Jul 2022

// PR NEWSWIRE

CorePharma's Generic Clorazepate Dipotassium Receives Approval in the U.S.

14 Jun 2022

// FDA

Italy bans 7 APIs from compounding pharmacies after off-label abuse

21 Aug 2015

// Fiona Barry IN-PHARMA TECHNOLOGIST

Clorazepate Dipotassium

Clorazepate Dipotassium

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

11 API Suppliers

7 USDMF

2 CEP/COS

1 JDMF

3 NDC API

5 Listed Suppliers

$ API Reference Price

INTERMEDIATES

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

114 FDF Dossiers

85 FDA Orange Book

25 Europe

3 Canada

1 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 11.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 22.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

1 DKSH

1 Jai Radhe Sales

5 Faran Shimi Pharmaceutical

7 Gangwal Healthcare

2 Actylis

1 Aeon Procare

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

5 BASF

3 DFE Pharma

1 Finar

5 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

1 Ingredion Pharma Solutions

3 Kerry

8 Microlex e.U

1 Pharmatrans-Sanaq

5 Pluviaendo

3 Prachin Chemical

8 Roquette

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

10 Sigachi Industries

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

22 Fillers, Diluents & Binders

15 Direct Compression

15 Lubricants & Glidants

14 Disintegrants & Superdisintegrants

11 Thickeners and Stabilizers

10 Granulation

8 Co-Processed Excipients

7 Controlled & Modified Release

5 Coating Systems & Additives

4 Parenteral

4 Taste Masking

3 Emulsifying Agents

2 Chewable & Orodispersible Aids

2 Film Formers & Plasticizers

2 API Stability Enhancers

2 Rheology Modifiers

1 Topical

1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

28 Finished Drug Prices

MARKET PLACE

2 APIs

REF. STANDARDS & IMPURITIES

3 EDQM

TABLET;ORAL - 11.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 22.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 3.75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 7.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons